[约翰·M·戈德曼教授 1938 - 2013] - Suppr

Suppr

超能文献

[Professor John M. Goldman 1938-2013].

作者信息

Mahon François-Xavier, Reiffers Josy, Nicolini Franck Emmanuel

出版信息

Bull Cancer. 2014 Mar;101(3):224.

PMID:24818262

Abstract

摘要

相似文献

[Professor John M. Goldman 1938-2013].

Bull Cancer. 2014 Mar;101(3):224.

Imatinib (Gleevec) as a paradigm of targeted cancer therapies.

Keio J Med. 2010;59(1):1-3. doi: 10.2302/kjm.59.1.

Brian Druker and Charles Sawyers receive the 2011 ASCI/Stanley J. Korsmeyer Award.

J Clin Invest. 2011 Apr;121(4):1227-8. doi: 10.1172/jci57942.

Investigator profile. Brian J. Druker, M.D. Interview by Vicki P. Glaser.

J Hematother Stem Cell Res. 2001 Dec;10(6):721-4. doi: 10.1089/152581601317210818.

Perspectives on the development of imatinib and the future of cancer research.

Nat Med. 2009 Oct;15(10):1149-52. doi: 10.1038/nm1009-1149.

Part I: Milestones in personalised medicine--imatinib.

Lancet Oncol. 2008 Jun;9(6):600. doi: 10.1016/S1470-2045(08)70152-9.

[Treatment of chronic myeloid leukemia with imatinib. A case of translational medicine].

Medicina (B Aires). 2010;70(3):293-6.

Professor John M. Goldman, CML pioneer 1938-2013.

Int J Hematol. 2014 Feb;99(2):103-4. doi: 10.1007/s12185-014-1499-9.

Professor John M Goldman, 1938-2013: gentleman and scholar.

Leukemia. 2014 May;28(5):1175-6. doi: 10.1038/leu.2014.36. Epub 2014 Mar 21.

[Optimizing current drugs].

Ann Pharm Fr. 2005 Jan;63(1):17-24. doi: 10.1016/s0003-4509(05)82246-1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Professor John M. Goldman 1938-2013].

Bull Cancer. 2014 Mar;101(3):224.

Imatinib (Gleevec) as a paradigm of targeted cancer therapies.

Keio J Med. 2010;59(1):1-3. doi: 10.2302/kjm.59.1.

Brian Druker and Charles Sawyers receive the 2011 ASCI/Stanley J. Korsmeyer Award.

J Clin Invest. 2011 Apr;121(4):1227-8. doi: 10.1172/jci57942.

Investigator profile. Brian J. Druker, M.D. Interview by Vicki P. Glaser.

J Hematother Stem Cell Res. 2001 Dec;10(6):721-4. doi: 10.1089/152581601317210818.

Perspectives on the development of imatinib and the future of cancer research.

Nat Med. 2009 Oct;15(10):1149-52. doi: 10.1038/nm1009-1149.

Part I: Milestones in personalised medicine--imatinib.

Lancet Oncol. 2008 Jun;9(6):600. doi: 10.1016/S1470-2045(08)70152-9.

[Treatment of chronic myeloid leukemia with imatinib. A case of translational medicine].

Medicina (B Aires). 2010;70(3):293-6.

Professor John M. Goldman, CML pioneer 1938-2013.

Int J Hematol. 2014 Feb;99(2):103-4. doi: 10.1007/s12185-014-1499-9.

Professor John M Goldman, 1938-2013: gentleman and scholar.

Leukemia. 2014 May;28(5):1175-6. doi: 10.1038/leu.2014.36. Epub 2014 Mar 21.

[Optimizing current drugs].

Ann Pharm Fr. 2005 Jan;63(1):17-24. doi: 10.1016/s0003-4509(05)82246-1.